A 26-WEEK TRIAL COMPARING EFFICACY AND SAFETY OF INSULIN DEGLUDEC/INSULIN ASPART BID AND INSULIN DEGLUDEC OD PLUS INSULIN ASPART IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS TREATED WITH BASAL INSULIN IN NEED OF TREATMENT INTENSIFICATION WITH MEALTIME INSULIN: